MTEX

Mannatech Inc

Add to Watchlist

$

9.230

-0.206(-2.183%)1D

Overview
Forecast
Valuation
Earnings

Line

|

Candle

1D

5D

1M

3M

6M

YTD

1Y

5Y

High

10.250

Open

10.200

VWAP

9.15

Vol

38.60K

Mkt Cap

17.55M

Low

8.100

Amount

353.29K

EV/EBITDA(TTM)

10.13

Total Shares

1.88M

EV

12.01M

EV/OCF(TTM)

--

P/S(TTM)

0.14

Mannatech, Incorporated is a global health and wellness solution provider. The Company develops and sells nutritional supplements, skin care and anti-aging products, and weight-management products that target optimal health and wellness. The Company's product category includes Integrative Health, Targeted Health, Weight and Fitness, Skin Care, and Essentials. Integrative Health includes Ambrotose Complex, Ambrotose AO, Advanced Ambrotose, Ambrotose Life, Catalyst, Cognitate, Manapol Powder, MannaBears, and others. Targeted Health includes BounceBack, CardioBALANCE, GI-ProBalance Slimstick, GI-Zyme, GI-Defense, Blood Sugar ProBalance, ImmunoSTART, and others. Weight and Fitness includes OsoLean, SPORT, TruHealth Fat Loss System and others. Skin Care includes Emprizone, FIRM with Ambrotose, FreshDen, and others. Essentials include Catalyst Multivitamin, Liver Support, Joint Support SUPERFOOD, Sleep Support gummies and Stress Support gummies.

Show More

Valuation Metrics

The current forward P/E ratio for Mannatech Inc (MTEX.O) is 0.00, compared to its 5-year average forward P/E of 0.00. For a more detailed relative valuation and DCF analysis to assess Mannatech Inc 's fair value, click here.

Forward PE

The forward P/E ratio is a valuation metric that divides a company's current stock price by its estimated future earnings per share over the next 12 months.

dotted line Image

N/A

5Y Average PE

0.00

Current PE

0.00

Overvalued PE

0.00

Undervalued PE

0.00

Forward EV/EBITDA

The forward EV/EBITDA ratio is a valuation metric that divides a company's enterprise value (EV) by its estimated future earnings before interest, taxes, depreciation, and amortization (EBITDA) over the next 12 months.

dotted line Image

N/A

5Y Average EV/EBITDA

0.00

Current EV/EBITDA

0.00

Overvalued EV/EBITDA

0.00

Undervalued EV/EBITDA

0.00

Forward PS

The forward P/S ratio is a valuation metric that divides a company's current stock price by its estimated future sales (or revenue) per share over the next 12 months.

dotted line Image

N/A

5Y Average PS

0.00

Current PS

0.00

Overvalued PS

0.00

Undervalued PS

0.00

Financials

Annual

Quarterly

FY2025Q1

YoY :

-9.63%

26.56M

Total Revenue

FY2025Q1

YoY :

-201.59%

-833.00K

Operating Profit

FY2025Q1

YoY :

-229.66%

-1.53M

Net Income after Tax

FY2025Q1

YoY :

-226.98%

-0.80

EPS - Diluted

FY2025Q1

YoY :

-202.43%

-1.86M

Free Cash Flow

FY2025Q1

YoY :

-3.71%

74.30

Gross Profit Margin - %

FY2025Q1

YoY :

-243.64%

-5.76

Net Margin - %

FY2025Q1

N/A

ROIC

Trading Trends

Insider

Insiders are Neutral. There are no significant trading trends over the last month.

Sold

0-3

Months

0.0

USD

0

3-6

Months

0.0

USD

0

6-9

Months

0.0

USD

0

0-12

Months

126.2K

USD

1

Bought

0-3

0

0.0

USD

Months

3-6

0

0.0

USD

Months

6-9

0

0.0

USD

Months

0-12

1

126.2K

USD

Months

Hedge Fund

Hedge Funds are Neutral. There are no significant trading trends over the last quarter.

Sold

0-3

Months

0.0

Volume

0

3-6

Months

0.0

Volume

0

6-9

Months

0.0

Volume

0

0-12

Months

0.0

Volume

0

Bought

0-3

0

0.0

Volume

Months

3-6

0

0.0

Volume

Months

6-9

0

0.0

Volume

Months

0-12

0

0.0

Volume

Months

Congress Trading

Congress are Neutral. There are no significant trading trends over the last month.

Sold

0-3

Months

0.0

USD

0

3-6

Months

0.0

USD

0

6-9

Months

0.0

USD

0

0-12

Months

0.0

USD

0

Bought

0-3

0

0.0

USD

Months

3-6

0

0.0

USD

Months

6-9

0

0.0

USD

Months

0-12

0

0.0

USD

Months

Insider

Insiders are Neutral. There are no significant trading trends over the last month.

Sold

0-3

Months

0.0

USD

0

3-6

Months

0.0

USD

0

6-9

Months

0.0

USD

0

0-12

Months

126.2K

USD

1

Bought

0-3

0

0.0

USD

Months

3-6

0

0.0

USD

Months

6-9

0

0.0

USD

Months

0-12

1

126.2K

USD

Months

MTEX News & Events

Events Timeline

2024-11-26 (ET)

2024-11-26

15:30:47

Mannatech names Robert Toth vice chairman of the board

Sign Up For More Events

Sign Up For More Events

News

5.0

06-26Newsfilter

Mannatech Announces Promotion of Peter Griscom to Chief Operating Officer

1.0

06-05Newsfilter

Mannatech Announces Results of Annual Shareholders' Meeting

1.0

05-21Newsfilter

Mannatech Premieres Powerful New Documentary on Marathon Legend Steve Edwards

Sign Up For More News

People Also Watch

Brand House Collective Inc

American Shared Hospital Services

Odyssey Marine Exploration Inc

Millennium Group International Holdings Ltd

Concord Medical Services Holdings Ltd

Athira Pharma Inc

FAQ

What is Mannatech Inc (MTEX) stock price today?

The current price of MTEX is 9.23 USD — it has decreased -2.18 % in the last trading day.

What is Mannatech Inc (MTEX)'s business?

What is the price predicton of MTEX Stock?

What is Mannatech Inc (MTEX)'s revenue for the last quarter?

What is Mannatech Inc (MTEX)'s earnings per share (EPS) for the last quarter?

What changes have occurred in the market's expectations for Mannatech Inc (MTEX)'s fundamentals?

How many employees does Mannatech Inc (MTEX). have?

What is Mannatech Inc (MTEX) market cap?